Botryosphaeria ribis

From WikiMD's Food, Medicine & Wellness Encyclopedia

Botryosphaeria ribis is a species of fungus in the family Botryosphaeriaceae. It is a plant pathogen that affects a wide range of host plants, causing diseases such as dieback, canker, and fruit rot.

Taxonomy[edit | edit source]

The species was first described in 1913 by George Edward Massee, a British mycologist. It belongs to the genus Botryosphaeria, which comprises over 18 species of fungi. The specific epithet ribis refers to the genus Ribes, as the fungus was first isolated from currant plants in this genus.

Description[edit | edit source]

Botryosphaeria ribis is characterized by its dark, globose ascocarps and elongated, hyaline ascospores. The fungus produces conidia in a separate, asexual stage known as the anamorph, which is referred to as Diplodia.

Pathogenicity[edit | edit source]

Botryosphaeria ribis is a significant plant pathogen. It infects a wide range of host plants, including fruit trees such as apple, pear, and peach, as well as ornamental plants and forest trees. The fungus enters the plant through wounds or natural openings and causes diseases such as dieback, canker, and fruit rot.

Management[edit | edit source]

Management of Botryosphaeria ribis involves a combination of cultural practices, chemical control, and biological control. Cultural practices include pruning and removal of infected plant material, while chemical control involves the use of fungicides. Biological control with antagonistic microorganisms is also being explored as a sustainable management strategy.

See also[edit | edit source]

This article is a stub.

Help WikiMD grow by registering to expand it.
Editing is available only to registered and verified users.
About WikiMD: A comprehensive, free health & wellness encyclopedia.

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD